Detalhe da pesquisa
1.
Preferential and persistent impact of acute HIV-1 infection on CD4+ iNKT cells in colonic mucosa.
Proc Natl Acad Sci U S A;
118(46)2021 11 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34753817
2.
Cerebrospinal fluid CD4+ T cell infection in humans and macaques during acute HIV-1 and SHIV infection.
PLoS Pathog;
17(12): e1010105, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34874976
3.
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge.
PLoS Pathog;
16(9): e1008764, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32881968
4.
Preferential Infection of α4ß7+ Memory CD4+ T Cells During Early Acute Human Immunodeficiency Virus Type 1 Infection.
Clin Infect Dis;
71(11): e735-e743, 2020 12 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32348459
5.
Using of endovascular catheter methods in surgical treatment patients with lung bleeding.
Wiad Lek;
73(6): 1149-1153, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32723943
6.
Pharmacologic Inhibition of Nedd8 Activation Enzyme Exposes CD4-Induced Epitopes within Env on Cells Expressing HIV-1.
J Virol;
90(5): 2486-502, 2015 Dec 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26676780
7.
Stimulation of NF-κB activity by the HIV restriction factor BST2.
J Virol;
87(4): 2046-57, 2013 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23221546
8.
HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions.
J Biol Chem;
287(1): 58-67, 2012 Jan 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22072710
9.
AP-1/c-Fos supports SIV and HIV-1 latency in CD4 T cells infected in vivo.
iScience;
26(10): 108015, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37860759
10.
Serine-threonine ubiquitination mediates downregulation of BST-2/tetherin and relief of restricted virion release by HIV-1 Vpu.
J Virol;
85(1): 51-63, 2011 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20980512
11.
Single-Cell Profiling of Latently SIV-Infected CD4+ T Cells Directly Ex Vivo to Reveal Host Factors Supporting Reservoir Persistence.
Microbiol Spectr;
10(3): e0060422, 2022 06 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35510859
12.
Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial.
Lancet HIV;
6(5): e297-e306, 2019 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31000477
13.
Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques.
J Vis Exp;
(139)2018 09 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30320741
14.
Structural basis of HIV-1 Vpu-mediated BST2 antagonism via hijacking of the clathrin adaptor protein complex 1.
Elife;
3: e02362, 2014 Apr 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24843023
15.
Theoretical investigation of planar square carbon allotrope and its hydrogenation.
J Phys Condens Matter;
24(17): 175501, 2012 May 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22469824
16.
Interferon-induced SCYL2 limits release of HIV-1 by triggering PP2A-mediated dephosphorylation of the viral protein Vpu.
Sci Signal;
5(245): ra73, 2012 Oct 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23047923
17.
Misdirection of membrane trafficking by HIV-1 Vpu and Nef: Keys to viral virulence and persistence.
Cell Logist;
1(3): 90-102, 2011 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21922073
18.
BST-2 is rapidly down-regulated from the cell surface by the HIV-1 protein Vpu: evidence for a post-ER mechanism of Vpu-action.
Virology;
411(1): 65-77, 2011 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21237475
19.
Antiviral activity of the interferon-induced cellular protein BST-2/tetherin.
AIDS Res Hum Retroviruses;
25(12): 1197-210, 2009 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19929170